SCHEMBL10153487

SCHEMBL10153487

c1ccc([Si](c2ccccc2)(c2cc3c4ccccc4n4c5ccccc5c(c2)c34)c2cc3c4ccccc4n4c5ccccc5c(c2)c34)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.36
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MAPT P10636 4/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
ALDH1A1 P00352 3/20 0.35
HPGD P15428 3/20 0.35
POLB P06746 2/20 0.35
GAA P10253 2/20 0.35
HTT P42858 1/20 0.35
GPR3 P46089 1/20 0.34
CYP1A2 P05177 1/20 0.33
CYP2C19 P33261 1/20 0.33
CYP19A1 P11511 1/20 0.33
PTPN1 P18031 1/20 0.33
HSD17B10 Q99714 3/20 0.33
TSHR P16473 1/20 0.33
CHEK1 O14757 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10153432 1.00 KDM4E (0.36) KDM4EATML3MBTL1MAPTMEN1
SCHEMBL10153435 0.88 MAOA (0.46) KDM4EALDH1A1POLBHTTCYP1A2
SCHEMBL10153509 0.86 KDM4E (0.38) KDM4EATML3MBTL1MAPTMEN1
SCHEMBL10153451 0.86 KDM4E (0.38) KDM4EATML3MBTL1MAPTMEN1
SCHEMBL25638839 0.82 KDM4E (0.41) KDM4EATML3MBTL1
SCHEMBL25639957 0.82 KDM4E (0.41) KDM4EATML3MBTL1
SCHEMBL24035024 0.82 KDM4E (0.34) KDM4EATML3MBTL1MAPTMEN1
SCHEMBL10153433 0.82 MAOA (0.39) KDM4EATMALDH1A1POLBHTT
SCHEMBL24035023 0.82 KDM4E (0.34) KDM4EATML3MBTL1MAPTMEN1
SCHEMBL10153898 0.82 MAOA (0.39) KDM4EATMALDH1A1POLBHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8421066-B2 Organic electroluminescence device UDC IRELAND LIMITED (IE) 2013-04-16 US disclosed
US-8421066-B2 Organic electroluminescence device UDC IRELAND LIMITED (IE) 2013-04-16 US disclosed
US-20120178928-A1 ORGANIC ELECTROLUMINESCENCE DEVICE FUJIFILM CORPORATION (JP) 2012-07-12 US disclosed
US-8174002-B2 Organic electroluminescence device FUJIFILM CORPORATION (JP) 2012-05-08 US disclosed
US-20100051928-A1 ORGANIC ELECTROLUMINESCENCE DEVICE FUJIFILM CORPORATION (JP) 2010-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100051928-A1 ORGANIC ELECTROLUMINESCENCE DEVICE L1CAM, CHRM1, LEF1 KDM4E 2229/4885ATM 3770/4885L3MBTL1 4/4885
US-20120178928-A1 ORGANIC ELECTROLUMINESCENCE DEVICE L1CAM, CHRM1, LEF1 KDM4E 2229/4885ATM 3770/4885L3MBTL1 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.